Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Jun;61(6):1498–1507. doi: 10.1172/JCI109070

von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.

R R Montgomery, T S Zimmerman
PMCID: PMC372676  PMID: 307007

Abstract

Factor VIII-related antigen (VIIIag) is deficient in plasma and platelets of patients with severe von Willebrand's disease. This study reports a second von Willebrand's disease antigen (vWagII), distinct from VIIIag, that is also deficient in the platelets and plasma of patients with severe von Willebrand's disease. VIIIag and vWagII are separable by molecular exclusion chromatography, sucrose density gradient ultracentrifugation, and crossed immunoelectrophoresis. They show reactions of immunologic nonidentity with each other, and thus, do not share a precursor-product relationship. vWagII is released from normal platelets during blood clotting, accounting for a fourfold higher concentration of vWagII in serum over plasma.

Full text

PDF
1502

Images in this article

1501Image
on p.1501
1501Image
on p.1501
1502Image
on p.1502
1503Image
on p.1503
1503Image
on p.1503
1504Image
on p.1504
1505Image
on p.1505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelsen N. H., Bock E., Kroll J. Comparison of antigens: the reaction of 'identity'. Scand J Immunol Suppl. 1973;1:91–94. doi: 10.1111/j.1365-3083.1973.tb03785.x. [DOI] [PubMed] [Google Scholar]
  2. Bock E., Axelsen N. H. Comparison of antigens: the reaction of partial identity. Scand J Immunol Suppl. 1973;1:95–99. doi: 10.1111/j.1365-3083.1973.tb03786.x. [DOI] [PubMed] [Google Scholar]
  3. Bouma B. N., Wiegerinck Y., Sixma J. J., Van Mourik J. A., Mochtar I. A. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease. Nat New Biol. 1972 Mar 29;236(65):104–106. doi: 10.1038/newbio236104a0. [DOI] [PubMed] [Google Scholar]
  4. Bowie E. J., Owen C. A., Jr Platelet abnormalities in von Willebrand's disease. Ann N Y Acad Sci. 1972 Oct 27;201:400–420. doi: 10.1111/j.1749-6632.1972.tb16313.x. [DOI] [PubMed] [Google Scholar]
  5. Coller B. S., Hirschman R. J., Gralnick H. R. Studies on the Factor VIII/von Willebrand factor antigen on human platelets. Thromb Res. 1975 Jun;6(6):469–480. doi: 10.1016/0049-3848(75)90059-6. [DOI] [PubMed] [Google Scholar]
  6. Curtiss L. K., Edgington T. S. Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol. 1976 May;116(5):1452–1458. [PubMed] [Google Scholar]
  7. Hellem A. J. Platelet adhesiveness in von Willebrand's disease. A study with a new modification of the glass bead filter method. Scand J Haematol. 1970;7(5):374–382. [PubMed] [Google Scholar]
  8. Howard M. A., Firkin B. G. Ristocetin--a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh. 1971 Oct 31;26(2):362–369. [PubMed] [Google Scholar]
  9. Howard M. A., Montgomery D. C., Hardisty R. M. Factor-VIII-related antigen in platelets. Thromb Res. 1974 May;4(5):617–624. doi: 10.1016/0049-3848(74)90218-7. [DOI] [PubMed] [Google Scholar]
  10. Howard M. A., Sawers R. J., Firkin B. G. Ristocetin: a means of differentiating von Willebrand's disease into two groups. Blood. 1973 May;41(5):687–690. [PubMed] [Google Scholar]
  11. Hoyer L. W. Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen. J Lab Clin Med. 1972 Dec;80(6):822–833. [PubMed] [Google Scholar]
  12. Hoyer L. W. Von Willebrand's disease. Prog Hemost Thromb. 1976;3:231–287. [PubMed] [Google Scholar]
  13. Jenkins C. S., Phillips D. R., Clemetson K. J., Meyer D., Larrieu M. J., Lüscher E. F. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest. 1976 Jan;57(1):112–124. doi: 10.1172/JCI108251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kroll J. Tandem-crossed immunoelectrophoresis. Scand J Immunol Suppl. 1973;1:57–59. [PubMed] [Google Scholar]
  15. LARRIEU M. J., SOULIER J. P. Déficit en facteur antihémophilique A chez une fille, associé a un trouble du saignement. Rev Hematol. 1953;8(3):361–370. [PubMed] [Google Scholar]
  16. Ludlam C. A., Cash J. D. Studies on liberation of beta-thromboglobulin from human platelets in vitro. Br J Haematol. 1976 Jun;33(2):239–247. doi: 10.1111/j.1365-2141.1976.tb03535.x. [DOI] [PubMed] [Google Scholar]
  17. Ludlam C. A., Moore S., Bolton A. E., Pepper D. S., Cash J. D. The release of a human platelet specific protein measured by a radioimmunoassay. Thromb Res. 1975 Jun;6(6):543–548. doi: 10.1016/0049-3848(75)90066-3. [DOI] [PubMed] [Google Scholar]
  18. Meyer D., Larrieu M. J. Von Willebrand factor and platelet adhesiveness. J Clin Pathol. 1970 Apr;23(3):228–231. doi: 10.1136/jcp.23.3.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. NIH conference. Factor VIII. Ann Intern Med. 1977 May;86(5):598–616. [PubMed] [Google Scholar]
  20. NILSSON I. M., BLOMBACK M., JORPES E., BLOMBACK B., JOHANSSON S. A. Von Willebrand's disease and its correction with human plasma fraction 1-0. Acta Med Scand. 1957 Nov 29;159(3):179–188. doi: 10.1111/j.0954-6820.1957.tb00123.x. [DOI] [PubMed] [Google Scholar]
  21. Nachman R., Levine R., Jaffe E. A. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest. 1977 Oct;60(4):914–921. doi: 10.1172/JCI108846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Niewiarowski S., Lowery C. T., Hawiger J., Millman M., Timmons S. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion. J Lab Clin Med. 1976 Apr;87(4):720–733. [PubMed] [Google Scholar]
  23. Shearn S. A., Giddings J. C., Peake I. R., Bloom A. L. A comparison of five different rabbit antisera to factor VIII and the demonstration of a factor VIII related antigen in normal and von Willebrand's disease platelets. Thromb Res. 1974 Nov;5(5):585–599. doi: 10.1016/0049-3848(74)90049-8. [DOI] [PubMed] [Google Scholar]
  24. Walsh R. T. The platelet in von Willebrand's disease: interactions with ristocetin and factor VIII. Semin Thromb Hemost. 1975 Oct;2(2):105–115. doi: 10.1055/s-0028-1086118. [DOI] [PubMed] [Google Scholar]
  25. Weeke B. Crossed immunoelectrophoresis. Scand J Immunol Suppl. 1973;1:47–56. doi: 10.1111/j.1365-3083.1973.tb03778.x. [DOI] [PubMed] [Google Scholar]
  26. Weiss H. J., Rogers J., Brand H. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. J Clin Invest. 1973 Nov;52(11):2697–2707. doi: 10.1172/JCI107464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zimmerman T. S., Edgington T. S. Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities. J Exp Med. 1973 Oct 1;138(4):1015–1020. doi: 10.1084/jem.138.4.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zimmerman T. S., Hoyer L. W., Dickson L., Edgington T. S. Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med. 1975 Jul;86(1):152–159. [PubMed] [Google Scholar]
  29. Zimmerman T. S., Ratnoff O. D., Powell A. E. Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. J Clin Invest. 1971 Jan;50(1):244–254. doi: 10.1172/JCI106480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Zimmerman T. S., Roberts J., Edgington T. S. Factor-VIII-related antigen: multiple molecular forms in human plasma. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5121–5125. doi: 10.1073/pnas.72.12.5121. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES